Search Results - "Tsubakihara, Y."

Tachycardia as a predictor of poor survival in chronic haemodialysis patients by ISEKI, Kunitoshi, NAKAI, Shigeru, YAMAGATA, Kunihiro, TSUBAKIHAN, Yoshiharu

“…High pulse rate is a culprit of all causes of death in the general population, but its relation to death in haemodialysis (HD) patients has not been examined…”
Get full text

A candidate gene approach to genetic contributors to the development of IgA nephropathy by YAMAMOTO, Ryohei, NAGASAWA, Yasuyuki, RAKUGI, Hiromi, ISAKA, Yoshitaka, SHOJI, Tatsuya, KATAKAMI, Naoto, OHTOSHI, Kentaro, HAYAISHI-OKANO, Rieko, YAMASAKI, Yoshimitsu, YAMAUCHI, Atsushi, TSUBAKIHARA, Yoshiharu, IMAI, Enyu

“…Genetic factors contributing to the development of IgA nephropathy remain to be elucidated. The present multicenter cross-sectional case-control study measured…”
Get full text

Higher survival rates of chronic hemodialysis patients on anti-hypertensive drugs by Iseki, K, Shoji, T, Nakai, S, Watanabe, Y, Akiba, T, Tsubakihara, Y

“…The effects of anti-hypertensive drugs on survival have not been examined in a large cohort of hemodialysis (HD) patients. We examined the relationship between…”
Get more information

Adenosine A1 receptor antagonist improves intradialytic hypotension by Imai, E., Fujii, M., Kohno, Y., Kageyama, H., Nakahara, K., Hori, M., Tsubakihara, Y.

“…Intradialytic hypotension is a most frequent complication of hemodialysis and may contribute to cardiovascular events and high mortality. There is a hypothesis…”
Get full text

Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study by UEHATA, Takuya, TOMOSUGI, Naohisa, ISAKA, Yoshitaka, RAKUGI, Hiromi, TSUBAKIHARA, Yoshiharu, SHOJI, Tatsuya, SAKAGUCHI, Yusuke, SUZUKI, Akira, KANEKO, Tetsuya, OKADA, Noriyuki, YAMAMOTO, Ryohei, NAGASAWA, Yasuyuki, KATO, Kiminori

Get full text

A candidate gene approach to genetic prognostic factors of IgA nephropathy—a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN) by Yamamoto, Ryohei, Nagasawa, Yasuyuki, Shoji, Tatsuya, Inoue, Kazunori, Uehata, Takuya, Kaneko, Tetsuya, Okada, Tomonori, Yamauchi, Atsushi, Tsubakihara, Yoshiharu, Imai, Enyu, Isaka, Yoshitaka, Rakugi, Hiromi

“…Background. Renal prognosis of IgA nephropathy (IgAN) is affected by environmental and genetic factors. Other studies demonstrated that some atherosclerotic…”
Get full text

High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy by MORIYAMA, T., KANEKO, T., FUJII, M., TSUBAKIHARA, Y., KAWANO, S., IMAI, E.

“…Summary Background Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases…”
Get full text

Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan by Furumatsu, Yoshiyuki, Nagasawa, Yasuyuki, Hamano, Takayuki, Iwatani, Hirotsugu, Iio, Kenichiro, Shoji, Tatsuya, Ito, Takahito, Tsubakihara, Yoshiharu, Imai, Enyu

“…Background. Erythropoietin (EPO) has been reported to slow the decline of renal function in predialysis chronic kidney disease (CKD) patients. On the contrary,…”
Get full text

Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients by Shoji, Tatsuya, Tsubakihara, Yoshiharu, Fujii, Masamitsu, Imai, Enyu

“…Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. The relationship between blood pressure (BP)…”
Get full text

A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan by Maruyama, Yukio, Taniguchi, Masatomo, Kazama, Junichiro J, Yokoyama, Keitaro, Hosoya, Tatsuo, Yokoo, Takashi, Shigematsu, Takashi, Iseki, Kunitoshi, Tsubakihara, Yoshiharu

“…Monitoring of serum alkaline phosphatase (ALP) is recommended in the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). However, unlike…”
Get full text

Interleukin-8 in chronic renal failure and dialysis patients by Nakanishi, I, Moutabarrik, A, Okada, N, Kitamura, E, Hayashi, A, Syouji, T, Namiki, M, Ishibashi, M, Zaid, D, Tsubakihara, Y

“…A total of 105 patients participated in this study, including 10 with chronic glomerulonephritis with normal renal function (CGN patients), 36 uraemic patients…”
Get more information

Urine Levels of CD46 (Membrane Cofactor Protein) Are Increased in Patients with Glomerular Diseases by Shoji, T., Nakanishi, I., Kunitou, K., Tsubakihara, Y., Hirooka, Y., Kishi, Y., Hatanaka, M., Matsumoto, M., Toyoshima, K., Seya, T.

“…Soluble membrane cofactor protein (MCP, CD46) has not been detected by conventional ELISA in human urine. Here, we established a highly sensitive assay method…”
Get full text

Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis by Yoshimoto, K, Saima, S, Nakamura, Y, Nakayama, M, Kubo, H, Kawaguchi, Y, Nishitani, H, Yasui, A, Yokoyama, K, Kuriyama, S, Shirai, D, Kugiyama, A, Hayano, K, Fukui, H, Horigome, I, Amagasaki, Y, Tsubakihara, Y, Kamekawa, T, Ando, R, Tomura, S, Okamoto, R, Miwa, S, Koyama, T, Echizen, H

“…We previously reported that manidipine, a new dihydropyridine type calcium channel blocker, produced chylous peritoneal dialysate being visually…”
Get more information

Acute rejection and the therapeutic choice of drug by Ichikawa, Y, Nojima, M, Kyo, M, Yazawa, K, Hanafusa, T, Ebisui, C, Tsubakihara, Y, Fukunishi, T, Nagano, S

Get full text

Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients by Moutabarrik, A, Nakanishi, I, Namiki, M, Tsubakihara, Y

“…We have assessed the levels of interleukin-1b (IL-1b) and interleukin-1 receptor antagonist (IL-1RA) in both serum and peritoneal dialysate effluents (PDE)…”
Get more information

Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine by Iida, N, Tsubakihara, Y, Shirai, D, Imada, A, Suzuki, M

“…L-threo-3,4-dihydroxyphenylserine (L-DOPS), a precursor of noradrenaline (norepinephrine), which is converted into noradrenaline when orally administered, was…”
Get more information

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan by Tanaka, Tetsuhiro, Nangaku, Masaomi, Imai, Enyu, Tsubakihara, Yoshiharu, Kamai, Masatoshi, Wada, Michihito, Asada, Shinji, Akizawa, Tadao

“…Background This post-marketing surveillance (PMS) study evaluated the safety and effectiveness of long-term darbepoetin alfa (darbepoetin) for the treatment of…”
Get full text

Arkadia enhances BMP signalling through ubiquitylation and degradation of Smad6 by Tsubakihara, Yutaro, Hikita, Atsuhiko, Yamamoto, Shin, Matsushita, Sachi, Matsushita, Natsuki, Oshima, Yusuke, Miyazawa, Keiji, Imamura, Takeshi

“…Arkadia, a positive regulator of Smad-dependent signalling via the transforming growth factor-β (TGF-β) family, is an E3 ubiquitin ligase that induces…”
Get full text

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure by Hayashi, Terumasa, Suzuki, Akira, Shoji, Tatsuya, Togawa, Masaki, Okada, Noriyuki, Tsubakihara, Yoshiharu, Imai, Enyu, Hori, Masatsugu

“…The optimal target hematocrit (Ht) level in recombinant human erythropoietin (rHuEPO) therapy remains controversial and has hardly been investigated in…”
Get full text

Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease by NIIHATA, Kakuya, TOMOSUGI, Naohisa, OKADA, Noriyuki, ISAKA, Yoshitaka, RAKUGI, Hiromi, TSUBAKIHARA, Yoshiharu, UEHATA, Takuya, SHOJI, Tatsuya, MITSUMOTO, Kensuke, SHIMIZU, Morihiro, KAWABATA, Hiroaki, SAKAGUCHI, Yusuke, SUZUKI, Akira, HAYASHI, Terumasa

“…Hepcidin is associated with iron-restricted erythropoiesis. A previous cross-sectional study showed that serum hepcidin-25 levels are negatively associated…”
Get full text